Prednisone Completed Phase 2 Trials for Non-Hodgkin's Lymphoma (NHL) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00151281Phase II Study of RT-PEPC in Relapsed Mantle Cell Lymphoma
NCT00184002Doxorubicin (Doxil) Combined With Rituxan, Cyclophosphamide, Vincristine and Prednisone in Newly Diagnosed Aggressive Non-Hodgkin's Lymphomas
NCT00842114Rituximab and CVP Plus Interferon for Follicular Non Hodgkins Lymphoma (NHL)
NCT00193479Combination Chemotherapy and Rituximab With Pegfilgrastim Followed by Rituximab, in Large B-Cell Non-Hodgkin's Lymphoma